104 related articles for article (PubMed ID: 1313751)
1. Protection from retinal necrosis by passive transfer of monoclonal antibody specific for herpes simplex virus glycoprotein D.
Atherton SS
Curr Eye Res; 1992 Jan; 11(1):45-52. PubMed ID: 1313751
[TBL] [Abstract][Full Text] [Related]
2. Sparing of the ipsilateral retina after anterior chamber inoculation of HSV-1: requirement for either CD4+ or CD8+ T cells.
Azumi A; Atherton SS
Invest Ophthalmol Vis Sci; 1994 Jul; 35(8):3251-9. PubMed ID: 7913918
[TBL] [Abstract][Full Text] [Related]
3. ACAID requires early replication of HSV-1 in the injected eye.
Atherton SS; Kanter MY; Streilein JW
Curr Eye Res; 1991; 10 Suppl():75-80. PubMed ID: 1650676
[TBL] [Abstract][Full Text] [Related]
4. Induction of bilateral retinal necrosis in mice by unilateral intracameral inoculation of a glycoprotein-C deficient clinical isolate of herpes simplex virus type 1.
Liu Y; Sakai Y; Minagawa H; Toh Y; Ishibashi T; Inomata H; Mori R
Arch Virol; 1993; 129(1-4):105-18. PubMed ID: 8385909
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of protection against herpes simplex virus type 1-induced retinal necrosis by in vitro-activated T lymphocytes.
Igietseme JU; Streilein JW; Miranda F; Feinerman SJ; Atherton SS
J Virol; 1991 Feb; 65(2):763-8. PubMed ID: 1846197
[TBL] [Abstract][Full Text] [Related]
6. Modulation of murine herpes simplex virus type 1 retinitis in the uninoculated eye by CD4+ T lymphocytes.
Azumi A; Cousins SW; Kanter MY; Atherton SS
Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):54-63. PubMed ID: 7905467
[TBL] [Abstract][Full Text] [Related]
7. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease.
Dix RD; Pereira L; Baringer JR
Infect Immun; 1981 Oct; 34(1):192-9. PubMed ID: 6271681
[TBL] [Abstract][Full Text] [Related]
8. Virus-specific DTH prevents contralateral retinitis following intracameral inoculation of HSV-2.
Atherton SS; Streilein JW
Curr Eye Res; 1987 Jan; 6(1):133-9. PubMed ID: 3030636
[TBL] [Abstract][Full Text] [Related]
9. T cells in the uninjected eye after anterior chamber inoculation of herpes simplex virus type 1.
Azumi A; Atherton SS
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):78-83. PubMed ID: 9430548
[TBL] [Abstract][Full Text] [Related]
10. Rapid spread of a neurovirulent strain of HSV-1 through the CNS of BALB/c mice following anterior chamber inoculation.
Archin NM; Atherton SS
J Neurovirol; 2002 Apr; 8(2):122-35. PubMed ID: 11935464
[TBL] [Abstract][Full Text] [Related]
11. Two waves of virus following anterior chamber inoculation of HSV-1.
Atherton SS; Streilein JW
Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):571-9. PubMed ID: 3030957
[TBL] [Abstract][Full Text] [Related]
12. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
Ritchie MH; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
[TBL] [Abstract][Full Text] [Related]
13. Passive immunization of mice with monoclonal antibodies to glycoprotein gB of herpes simplex virus.
Kino Y; Eto T; Ohtomo N; Hayashi Y; Yamamoto M; Mori R
Microbiol Immunol; 1985; 29(2):143-9. PubMed ID: 2989659
[TBL] [Abstract][Full Text] [Related]
14. Protection of mice from herpes simplex virus-induced retinitis by in vitro-activated immune cells.
Igietseme JU; Calzada PJ; Gonzalez AR; Streilein JW; Atherton SS
J Virol; 1989 Nov; 63(11):4808-13. PubMed ID: 2552154
[TBL] [Abstract][Full Text] [Related]
15. Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1-disparate congenic murine strains.
Hemady R; Tauber J; Ihley TM; Opremcak EM; Foster CS
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2335-41. PubMed ID: 2173686
[TBL] [Abstract][Full Text] [Related]
16. Prevention of herpes keratitis by monoclonal antibodies specific for discontinuous and continuous epitopes on glycoprotein D.
Lousch RN; Staats H; Oakes JE; Cohen GH; Eisenberg RJ
Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2735-40. PubMed ID: 1716618
[TBL] [Abstract][Full Text] [Related]
17. Protection against murine cytomegalovirus retinitis by adoptive transfer of virus-specific CD8+ T cells.
Bigger JE; Tanigawa M; Thomas CA; Atherton SS
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2608-13. PubMed ID: 10509656
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
19. HSV-1 retinitis and delayed hypersensitivity in DBA/2 and C57BL/6 mice.
Kielty D; Cousins SW; Atherton SS
Invest Ophthalmol Vis Sci; 1987 Dec; 28(12):1994-9. PubMed ID: 2824401
[TBL] [Abstract][Full Text] [Related]
20. The regulation by light of retinal necrosis and the immune response following anterior chamber inoculation of herpes simplex virus type-1.
Kahn M; Kaplan HJ; Ferguson TA
Arch Virol; 1993; 131(1-2):115-26. PubMed ID: 8392317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
